The Trump administration issued an executive order earlier this month to accelerate access to psychedelic medication for people with serious mental illnesses, but experts say the order is more likely to make a difference symbolically than legally.
The order lists provisions including inter-agency collaboration with the Department of Veterans Affairs to share data and increase clinical trial participation, and timely rescheduling if an illegal psychedelic receives FDA approval. Mason Marks, a law professor at Florida State University, said the concrete provisions would likely have only minimal impact, but the overall order could have significant symbolic value.
The order was promoted at a press conference with podcaster Joe Rogan and former Navy Seal Marcus Luttrell. Rogan said a text conversation with the president inspired the order. Cat Packer of the Drug Policy Alliance said the order signals who is influencing the administration, noting expanding Republican support for psychedelics.
Packer cautioned that the medicalised, veteran-centred framework could limit who benefits, and without investments in healthcare access and housing, the mental health crisis cannot be addressed. Trump issued a similar order on cannabis in December, but rescheduling has faced institutional resistance, with the acting attorney general only recently announcing an expedited hearing.
